SPDEF and prostate cancer: The potential role of the non-fusion epithelial-specific Ets factor, SPDEF, as prostate cancer tumor and metastasis suppressor recently emerged, demonstrating that SPDEF expression loss in advanced prostate cancer correlates with poor outcome [5-11].